kynurenic acid has been researched along with Cytokine Release Syndrome in 1 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y | 1 |
| Kim, DJ | 1 |
| Takahashi, T | 1 |
| Broadhurst, DI | 1 |
| Yan, H | 1 |
| Ma, S | 1 |
| Rattray, NJW | 1 |
| Casanovas-Massana, A | 1 |
| Israelow, B | 1 |
| Klein, J | 1 |
| Lucas, C | 1 |
| Mao, T | 1 |
| Moore, AJ | 1 |
| Muenker, MC | 1 |
| Oh, JE | 1 |
| Silva, J | 1 |
| Wong, P | 1 |
| Ko, AI | 1 |
| Khan, SA | 1 |
| Iwasaki, A | 1 |
| Johnson, CH | 1 |
1 other study available for kynurenic acid and Cytokine Release Syndrome
| Article | Year |
|---|---|
Kynurenic acid may underlie sex-specific immune responses to COVID-19.
Topics: Adult; Aged; Case-Control Studies; COVID-19; Cytokine Release Syndrome; Cytokines; Female; Humans; K | 2021 |